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multiple centres in UK, Italy, The Netherlands and Poland. For each country, pub-
lished local costs have been applied to the resource use. Results have been strati-
fied by glomerular filtration rate (GFR) at one-year post-transplant. RESULTS:
Across these countries, the total three-year cost of post-transplant care varies
depending on local treatment practices, from a minimum of €36,000 per patient in
Poland to a maximum of €77,000 in the The Netherlands. Consistently across all
countries, the average three-year costs decrease as a result of improved graft func-
tioning status (increased GFR) at one year. The average three-year costs for a pa-
tient with a GFR45 at one year are 29% lower than those with 30GFR in the The
Netherlands, 40% lower in Italy, 43% lower in Belgium, 50% lower in the UK, and
51% lower in Poland. CONCLUSIONS: This study demonstrates that in five Euro-
pean countries, worsening post-transplant renal function contributes to substan-
tive increases in resource use, with some variation across regions. Therefore man-
agement strategies that promote renal function after transplantation are likely to
provide important resource savings. Additional analyses are ongoing in Spain,
Czech Republic, Hungary, Germany and Sweden to further confirm these observa-
tions.
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EFFECTIVENESS ANALYSIS
Navarro espigares JL1, Hernandez torres E1, Ruiz arranz JL2
1Hospital Universitario Virgen De Las Nieves, Granada, Spain, 2Area Sanitaria Serrania De
Ronda, Ronda, Spain
OBJECTIVES: The main objective of this study is to evaluate the cost-effectiveness
of total hip arthroplasty through anterolateral minimally invasive surgery (MIS)
and compare it with the traditional approach. METHODS: A study was conducted
to compare traditional and minimally invasive surgical techniques for total hip
arthroplasty in a population of 340 patients at two Spanish hospitals (the Virgen de
las Nieves University Hospital of Granada and the Serranía de Ronda Hospital)
during the year 2007. The design of the study was a prospective stochastic cost-
effectiveness analysis, where effectiveness data were collected over a one-year
period at individual patient levels and costs were gathered from the analytical
accounting system of Virgen de las Nieves University Hospital. Effectiveness was
measured in functional terms (clinical) and self-perceived quality of life (SF-12
survey) during the first 6 postoperative weeks. RESULTS: After 6 postoperative
weeks, in comparison with the conventional technique, a pattern in improvements
for MIS was observed for length of hospital stay (hospitalization time was 4.97 days
shorter); for operative time (an average of 83.3 minutes for MIS patients and 97.8
minutes for the control group); and for average length of skin incision (9.83 cm. for
the MIS group and 16.2 cm. for the control group). The total cost of THA with MIS
was lower (4519.19 €) than the cost of traditional hip replacement (6722.46 €). In-
cremental effectiveness value in terms of quality of life was 0.11 points in the SF-12
survey for MIS. The cost-effectiveness analysis reveals a strong dominance of MIS
versus traditional THA. CONCLUSIONS: The study showed that the minimally in-
vasive technique reduces inpatient resource utilization and improves self per-
ceived quality of life of patients compared with the traditional approach. The more
beneficial incremental effectiveness ratio of MIS versus traditional THA supports
the recommendation for expanded use of minimally invasive surgery.
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OBJECTIVES: To perform a comparative cost-effectiveness analysis of Descemet’s
stripping automated endothelial keratoplasty (DSAEK) and penetrating kerato-
plasty (PK) for corneal endothelial disease. METHODS: Systematic review of the
peer-reviewed English literature through a search of PubMed to populate a 5 year
model of a) quality adjusted life years (QALYs) associated with clinical outcomes of
the relatively new DSAEK procedure and the long-established PK procedure, and b)
third party payer (US Medicare 2010) costs associated with associated medical,
surgical and pharmaceutical services. RESULTS: Five year follow-up focusing on
standard therapy and complications yeilds 2.99 QALYs associated with DSEAK and
1.94 QALYs with PK, a difference of 1.05. Following slightly higher sugical costs of
$US7925 for DSEAK and $US7544 for PK, total five year costs are $US10,104 associ-
ated with DSEAK and $US9840 with PK, a difference of $US264. The ICUR is $US251.
Sensitivity analyses of differeing disc dislocation rates, astigmtism complication
rates and cost parameters yield ICURs in the range of $US0 to $US500.
CONCLUSIONS: Using the literature on outcomes and costs for treatments of cor-
neal endothelial disease, a five year model yields robust results siggesting that
DSEAK is slightly more expensive procedure than PK to third party payers, but with
favorable quality adjusted life year resulting making DSEAK a cost-effective option
under all scenarios considered.
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OBJECTIVES: To assess the comparative efficiency of laparoscopic versus open
surgery in colorectal cancer patients. METHODS: To establish relative efficacy of
laparoscopic versus open surgery in all measures that could have clinical or eco-
nomic relevance. Using previous systematic reviews and updating their contents
with the new information published after. Meta-analysis technique is used to sum-
marize the information. A Markov model is developed to estimate progress in time
of health and resource use obtained with these two alternatives. Measures of
health outcomes used in the model were life years and quality adjusted life years.
Probabilistic sensitivity analysis was performed to assess uncertainty in the pa-
rameters included in the Markov model. RESULTS: Preliminary results show that
cost of laparoscopic-assisted surgery is higher than open surgery in close to 750 €.
This difference decreased slightly in the immediate postoperative period due to the
lower readmission rate. The difference in costs, coupled with the equivalence in
long-term results obtained by the two techniques makes that any of them can be
considered efficient for our health system. Since considering a willingness to pay
between 20,000 and 30,000 € per quality-adjusted life year gained, none of the
alternatives have above 60% chance to be the best option. CONCLUSIONS: The
laparoscopic-assisted resection has shown results in terms of overall survival and
recurrence similar to those achieved by open surgery in colorectal surgery patients.
The estimated cost for laparoscopic intervention is slightly higher than open sur-
gery, but seems to accelerate the postoperative recovery time. This implies that
none of the two alternatives is clearly superior to the other in terms of efficiency.
Therefore, each decision maker at hospital level will assess available human and
material resources, and its cost structure to use resources more efficiently.
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OBJECTIVES:A cost-utility analysis was conducted alongside the Danish On-pump
Off-pump Randomization Study (DOORS) based on the intention to treat principle.
METHODS: A post hoc analysis of the problem of missing data was addressed by
multiple imputation using the conditional Gaussian as well as the chained equa-
tion approach. Both methods where applied using two different models (represent-
ing a data-driven respectively a clinical reasoning selection strategy). RESULTS:
The cost-effectiveness acceptability curve for the complete case analysis (n779)
showed 88 % probability of OPCAB being cost-effective at a threshold value of
£30.000 per QALY. In analyses based on the conditional Gaussians approach and
the chained equations approach to multiple imputation the results was 73-75 %.
CONCLUSIONS: The result of the previously published complete-case analysis of
the cost-effectiveness of OPCAB versus CCABG was reinforced by this post hoc
analysis of the uncertainty due to missing data. The analysis showed that the
conditional Gaussian approach and the chained equations approach produced
similar results Evidence about the long term cost-effectiveness of OPCAB versus
CCABG is warranted.
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OBJECTIVES: The high variability on preferences estimates for prostate cancer
could be explained by differences in methods, techniques and obtaining popula-
tions. Our aim was to estimate the preferences and willingness to pay of patients in
the “Spanish Multicenter Study of Localized Prostate Cancer” at 5 years of follow-
up, according to the treatment received (radical prostatectomy, external radiother-
apy and brachytherapy).METHODS:Data analyzed were from the 5-year follow-up
evaluation of the “Spanish Multicenter Study of Localized Prostate Cancer”, in
which patients completed the preference questionnaire. The estimation of prefer-
ences was conducted using the indirect method (from the SF-6D index), and the
direct method using the Standard Gamble (SG) and Time Trade-Off (TTO) tech-
niques. We also assessed the patients’ Willingness-to Pay (WTP). The three treat-
ment groups were compared using the Kruskall Wallis test. RESULTS: Of the 441
patients enrolled, 105 were treated with radical prostatectomy, 137 with external
radiotherapy and 199 with prostate brachytherapy. Most patients were married or
living with a partner (89.6%), were retired (76%) and had completed primary or
secondary studies (53.5%). Utilities measured with the SF-6D showed no statisti-
cally significant differences by treatment group (p  0.356). The utilities measured
by TTO presented the greatest differences according to treatment: mean of 0.94 in
the radical prostatectomy group, 0.99 in external radiotherapy and 0.98 in brachy-
therapy (p 0.001). The willingness to pay also showed significant differences:
mean of 58.4 € in the radical prostatectomy group, 32.04 € in external radiotherapy
and 28.8 € in brachytherapy (p0.01).CONCLUSIONS:The estimates of preferences
vary according to the method and the technique used to obtain them. Both the
utilities obtained by the direct method and the ones through willingness to pay
indicate that radical prostatectomy is the worst valued treatment, prostate brachy-
therapy being the most valued by patients with localized prostate cancer.
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